If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
Clinical Trials Insight
£25.00 €47.50 $58.00 2012 Vol. 1
GlobalData
New frontiers
for clinical data
Pierre-Yves Lastic of Sanofi talks clinical
data management and CDISC
Making the right outsourcing choice ■ Opportunities in emerging markets ■ Adaptive design in clinical trials
To a courier, this is just another box.
To Marken, this is a fragile drug in
your Phase III clinical trial.
When a study depends on the integrity of the drug being administered, any excursions can compromise the entire
clinical trial. At Marken, we understand this better than anyone because Life Science is our business. Marken is led
by experts from the pharma industry with deep knowledge of worldwide logistics and pharma regulations. Our global
Pharmaceutical Service Network is purpose-built for the secure storage and distribution of your valuable IMPs and medical
devices,whileourt
Clinical Trials Insight £25.00 €47.50 $58.00
To a courier, this is just another box. To M
From the editor On the web... Keep up with the la
Contents In this issue 18 Cover stor
Contents 27 56 How do you determine shelf li
Market analysis > Statistics In development Based
Market analysis > Statistics industry and an in
Market analysis > Statistics negatively affecte
Market intelligence > Vital statistics M&A and
Insight > Clinical supply Changing trends in earl
Insight > Clinical supply designing placebo-con
Insight > CRO management Outsourcing: building a
Insight > CRO management “Endo is a mid-si
Insight > Emerging markets Eastern Europe com
Insight > Emerging markets one of the first to
Insight > Emerging markets Tips for selecting a
Insight > Study efficiency Follow the leader
Insight > Study efficiency If the bioscien
Insight > Data management Shaping the fu
Insight > Data management instance, th
Insight > Data management Figure 1. Current adop
Power your clinical studies with the most in
Why it's called good practice, not g
Company insight > Data management CDISC impleme
Company insight > Data management The quality d
Insight > Clinical supply Off the shelf? How do y
Insight > Clinical supply Lessons to learn n Thi
Company insight > Clinical supply How packaging
Company insight > Clinical supply Patients
Does your compliance package comply with the laws
Company insight > Clinical supply Benefits of sm
Think small, think big, TEMPERATURE CONTROLL
Company insight > Clinical supply The successf
Company insight > Clinical supply Optimal plan
Company insight > Clinical supply cases can be
Your clinical trials are valuable Cl
Company insight > Clinical supply Secure your
To a courier, this is just another box. To M
Company insight > Clinical supply Tailor-made b
Insight > Cold chain Cool
Insight > Cold chain I n July 2011
Insight > Cold chain that can contribute to th
Insight > Innovation What is an adaptive clinic
Insight > Innovation Among the many ideas
Insight > Innovation process, leading to a num
Company insight > Innovation Innovative trial d
Company insight > Innovation
INNOVATIVE, RESPONSIBLE GLOBAL PHARMACEUTICAL PRO
Insight > Comparator drugs Comparator tactics i
Insight > Comparator drugs trials is sourcing
Insight > Comparator drugs import licences or
Company insight > Comparator drugs Comparator s
Company insight > Comparator drugs
Insight > Clinical trial recruitment
Insight > Clinical trial recruitment In
Directory > Events Clinical trials events A look
Arena International's Clinical Trial Supply
Power your clinical studies with the most integra